A2A adenosine receptor — Drug Target

All drugs that target A2A adenosine receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Adenosine receptor agonist

Marketed (1)

• Regadenoson · Pfizer Inc. · Adenosine receptor agonist · Cardiovascular
  Regadenoson is a low affinity A2A adenosine receptor agonist that produces coronary vasodilation and increases coronary blood flow.